Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials

Overview

Inceptive is a company founded in 2021 by a co-author of the transformer paper to design RNA molecules with deep learning. It treats messenger and other RNA as programmable biological software, training models on large experimental datasets it generates itself. The goal is to write molecules that produce a desired biological effect rather than screening existing candidates.

News

News pharmexec.com 15 days ago
Alnylam Enters $2 Billion Strategic AI Collaboration with Inceptive PharmExec
Alnylam Pharmaceuticals has partnered with Inceptive to apply generative AI to siRNA design, pairing Inceptive
Read more
Report
News STAT 3 months ago
Alnylam to partner with Inceptive Nucleics for AI foundation models for RNAi therapeutics
Alnylam announced a three-year collaboration with Inceptive, worth up to $2 billion, with $30 million up front in cash and equity in the startup.
Read more
Report
Press release Nasdaq 3 months ago
Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics
CAMBRIDGE, Mass.& PALO ALTO, Calif.---- Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, and Inceptive Nucleics, Inc., which builds foundation models of life, today announced a strategic collaboration agreement to increase the pace of
Read more
Report
Pro access
Upgrade to see all 8 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.

Technologies

Sign in to see how your skills match this stack
Sign In
Tech DNA
Python
AI/ML
Python
Edge AI
Other
Linear
Notion
Stack modernity Modern
64/100
How modern this stack is, based on technology relevance, AI adoption and the share of legacy tools.
In-demand technologies
Python 3 jobs Required
$240k +30% vs market
Linear 1 job Required
$240k +33% vs market
Notion 1 job Required
$240k +41% vs market
Edge AI 1 job Required
$240k +14% vs market
Salary medians are calculated from this company's open jobs and compared with the market.
Stack changes
Notion Sep 2026
Linear Sep 2026
Edge AI Sep 2026
Python Aug 2026
Technologies recently added to or removed from this company's stack - a signal of tech migrations and new initiatives.

Salary insights

Compensation ranges based on this company's open jobs
Median
$240k
Typical range
$240k – $305k
Open positions
6
5 Jobs
Middle 60%
Senior 40%
Level Jobs Median Typical range
Middle 3 $240k $240k
Senior 2 $273k $240k – $305k
Highest paying role Leading Data-Driven Lab for AI Medicines $305k
Normalized to USD per year

Growth

Hiring Momentum
58/100
Growing
Open positions
6
0 opened / 0 closed in 30 days
ATS activity
Every ~20 hours
09/08/2026
Hiring Dynamics +100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Science & Research
100%
Activity Timeline
Added Notion to stack Sep 2026
Added Linear to stack Sep 2026
Added Edge AI to stack Sep 2026
Added Python to stack Aug 2026

Offices

Where the company hires and what each office is for
Cities
3
Hiring now
1
Countries
3
Busiest office
Palo Alto
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
Palo Alto United States
HQ
Palo Alto
6 open roles 2 posted in 90 days 67% engineering $251k Avg Salary
hires for Science & Research, Sales, Data Science
3440 Hillview Ave, D100, Palo Alto, CA, 94304, US
seen since Sep 2023 careers board, company site, job postings
Berlin Germany
Regional office
Berlin
careers board
Zurich Switzerland
Regional office
Zurich
careers board

Jobs

$221k – $305k per year • In office • 6+ years exp • PhD • Palo Alto
Python
Apply